nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0807	0.21	CbGbCtD
Naltrexone—ABCB1—Betamethasone—rheumatoid arthritis	0.0525	0.137	CbGbCtD
Naltrexone—ABCB1—Prednisolone—rheumatoid arthritis	0.0518	0.135	CbGbCtD
Naltrexone—ABCB1—Hydrocortisone—rheumatoid arthritis	0.0491	0.128	CbGbCtD
Naltrexone—ABCB1—Prednisone—rheumatoid arthritis	0.0489	0.127	CbGbCtD
Naltrexone—ABCB1—Cyclosporine—rheumatoid arthritis	0.0464	0.121	CbGbCtD
Naltrexone—ABCB1—Dexamethasone—rheumatoid arthritis	0.0305	0.0794	CbGbCtD
Naltrexone—ABCB1—Methotrexate—rheumatoid arthritis	0.0245	0.0638	CbGbCtD
Naltrexone—Naloxone—TLR4—rheumatoid arthritis	0.00461	0.889	CrCbGaD
Naltrexone—Naloxone—ALB—rheumatoid arthritis	0.000576	0.111	CrCbGaD
Naltrexone—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.000273	0.000604	CcSEcCtD
Naltrexone—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.000272	0.000603	CcSEcCtD
Naltrexone—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.000272	0.000602	CcSEcCtD
Naltrexone—Convulsion—Dexamethasone—rheumatoid arthritis	0.000271	0.000601	CcSEcCtD
Naltrexone—Convulsion—Betamethasone—rheumatoid arthritis	0.000271	0.000601	CcSEcCtD
Naltrexone—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000271	0.000599	CcSEcCtD
Naltrexone—Hypertension—Betamethasone—rheumatoid arthritis	0.00027	0.000599	CcSEcCtD
Naltrexone—Hypertension—Dexamethasone—rheumatoid arthritis	0.00027	0.000599	CcSEcCtD
Naltrexone—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000269	0.000595	CcSEcCtD
Naltrexone—Urticaria—Cyclosporine—rheumatoid arthritis	0.000267	0.000592	CcSEcCtD
Naltrexone—Myalgia—Dexamethasone—rheumatoid arthritis	0.000267	0.000591	CcSEcCtD
Naltrexone—Myalgia—Betamethasone—rheumatoid arthritis	0.000267	0.000591	CcSEcCtD
Naltrexone—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000266	0.00059	CcSEcCtD
Naltrexone—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.000266	0.00059	CcSEcCtD
Naltrexone—Anxiety—Dexamethasone—rheumatoid arthritis	0.000266	0.000589	CcSEcCtD
Naltrexone—Anxiety—Betamethasone—rheumatoid arthritis	0.000266	0.000589	CcSEcCtD
Naltrexone—Discomfort—Betamethasone—rheumatoid arthritis	0.000263	0.000584	CcSEcCtD
Naltrexone—Discomfort—Dexamethasone—rheumatoid arthritis	0.000263	0.000584	CcSEcCtD
Naltrexone—Pain—Prednisolone—rheumatoid arthritis	0.000262	0.00058	CcSEcCtD
Naltrexone—Hepatitis—Methotrexate—rheumatoid arthritis	0.000262	0.00058	CcSEcCtD
Naltrexone—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.00026	0.000576	CcSEcCtD
Naltrexone—Pharyngitis—Methotrexate—rheumatoid arthritis	0.00026	0.000576	CcSEcCtD
Naltrexone—Nausea—Leflunomide—rheumatoid arthritis	0.000259	0.000574	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000258	0.000572	CcSEcCtD
Naltrexone—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000258	0.000571	CcSEcCtD
Naltrexone—Vision blurred—Prednisone—rheumatoid arthritis	0.000257	0.000569	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000257	0.000569	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000256	0.000567	CcSEcCtD
Naltrexone—Pain—Hydrocortisone—rheumatoid arthritis	0.000256	0.000567	CcSEcCtD
Naltrexone—Oedema—Dexamethasone—rheumatoid arthritis	0.000256	0.000566	CcSEcCtD
Naltrexone—Oedema—Betamethasone—rheumatoid arthritis	0.000256	0.000566	CcSEcCtD
Naltrexone—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000256	0.000566	CcSEcCtD
Naltrexone—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000256	0.000566	CcSEcCtD
Naltrexone—Insomnia—Triamcinolone—rheumatoid arthritis	0.000255	0.000564	CcSEcCtD
Naltrexone—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000254	0.000563	CcSEcCtD
Naltrexone—Infection—Dexamethasone—rheumatoid arthritis	0.000254	0.000563	CcSEcCtD
Naltrexone—Infection—Betamethasone—rheumatoid arthritis	0.000254	0.000563	CcSEcCtD
Naltrexone—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000253	0.000561	CcSEcCtD
Naltrexone—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000253	0.00056	CcSEcCtD
Naltrexone—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000252	0.000559	CcSEcCtD
Naltrexone—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000252	0.000559	CcSEcCtD
Naltrexone—Shock—Betamethasone—rheumatoid arthritis	0.000251	0.000557	CcSEcCtD
Naltrexone—Shock—Dexamethasone—rheumatoid arthritis	0.000251	0.000557	CcSEcCtD
Naltrexone—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000251	0.000556	CcSEcCtD
Naltrexone—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000251	0.000555	CcSEcCtD
Naltrexone—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000251	0.000555	CcSEcCtD
Naltrexone—Agitation—Prednisone—rheumatoid arthritis	0.000251	0.000555	CcSEcCtD
Naltrexone—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000249	0.000553	CcSEcCtD
Naltrexone—Tachycardia—Betamethasone—rheumatoid arthritis	0.000249	0.000553	CcSEcCtD
Naltrexone—Angioedema—Prednisone—rheumatoid arthritis	0.000249	0.000552	CcSEcCtD
Naltrexone—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000248	0.000549	CcSEcCtD
Naltrexone—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000247	0.000547	CcSEcCtD
Naltrexone—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000247	0.000547	CcSEcCtD
Naltrexone—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000247	0.000546	CcSEcCtD
Naltrexone—Malaise—Prednisone—rheumatoid arthritis	0.000246	0.000545	CcSEcCtD
Naltrexone—Eye disorder—Methotrexate—rheumatoid arthritis	0.000245	0.000542	CcSEcCtD
Naltrexone—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000245	0.000542	CcSEcCtD
Naltrexone—Syncope—Prednisone—rheumatoid arthritis	0.000245	0.000542	CcSEcCtD
Naltrexone—Tinnitus—Methotrexate—rheumatoid arthritis	0.000244	0.000541	CcSEcCtD
Naltrexone—Anorexia—Dexamethasone—rheumatoid arthritis	0.000244	0.00054	CcSEcCtD
Naltrexone—Anorexia—Betamethasone—rheumatoid arthritis	0.000244	0.00054	CcSEcCtD
Naltrexone—Urticaria—Prednisolone—rheumatoid arthritis	0.000243	0.000539	CcSEcCtD
Naltrexone—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000243	0.000538	CcSEcCtD
Naltrexone—Fatigue—Triamcinolone—rheumatoid arthritis	0.000243	0.000538	CcSEcCtD
Naltrexone—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000242	0.000537	CcSEcCtD
Naltrexone—Asthenia—Cyclosporine—rheumatoid arthritis	0.000242	0.000535	CcSEcCtD
Naltrexone—Pain—Triamcinolone—rheumatoid arthritis	0.000241	0.000534	CcSEcCtD
Naltrexone—Loss of consciousness—Prednisone—rheumatoid arthritis	0.00024	0.000531	CcSEcCtD
Naltrexone—Pruritus—Cyclosporine—rheumatoid arthritis	0.000238	0.000528	CcSEcCtD
Naltrexone—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000238	0.000527	CcSEcCtD
Naltrexone—Angiopathy—Methotrexate—rheumatoid arthritis	0.000238	0.000526	CcSEcCtD
Naltrexone—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000236	0.000524	CcSEcCtD
Naltrexone—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000236	0.000524	CcSEcCtD
Naltrexone—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000236	0.000524	CcSEcCtD
Naltrexone—Convulsion—Prednisone—rheumatoid arthritis	0.000236	0.000524	CcSEcCtD
Naltrexone—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000236	0.000523	CcSEcCtD
Naltrexone—Hypertension—Prednisone—rheumatoid arthritis	0.000235	0.000522	CcSEcCtD
Naltrexone—Chills—Methotrexate—rheumatoid arthritis	0.000235	0.000521	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000233	0.000516	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000233	0.000516	CcSEcCtD
Naltrexone—Myalgia—Prednisone—rheumatoid arthritis	0.000232	0.000514	CcSEcCtD
Naltrexone—Arthralgia—Prednisone—rheumatoid arthritis	0.000232	0.000514	CcSEcCtD
Naltrexone—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000232	0.000514	CcSEcCtD
Naltrexone—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000232	0.000513	CcSEcCtD
Naltrexone—Anxiety—Prednisone—rheumatoid arthritis	0.000231	0.000513	CcSEcCtD
Naltrexone—Alopecia—Methotrexate—rheumatoid arthritis	0.000231	0.000513	CcSEcCtD
Naltrexone—Insomnia—Betamethasone—rheumatoid arthritis	0.000231	0.000512	CcSEcCtD
Naltrexone—Insomnia—Dexamethasone—rheumatoid arthritis	0.000231	0.000512	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000231	0.000511	CcSEcCtD
Naltrexone—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.00023	0.00051	CcSEcCtD
Naltrexone—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.00023	0.000509	CcSEcCtD
Naltrexone—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.00023	0.000508	CcSEcCtD
Naltrexone—Paraesthesia—Betamethasone—rheumatoid arthritis	0.00023	0.000508	CcSEcCtD
Naltrexone—Discomfort—Prednisone—rheumatoid arthritis	0.000229	0.000508	CcSEcCtD
Naltrexone—Mental disorder—Methotrexate—rheumatoid arthritis	0.000229	0.000508	CcSEcCtD
Naltrexone—Malnutrition—Methotrexate—rheumatoid arthritis	0.000228	0.000505	CcSEcCtD
Naltrexone—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000226	0.0005	CcSEcCtD
Naltrexone—Urticaria—Triamcinolone—rheumatoid arthritis	0.000224	0.000496	CcSEcCtD
Naltrexone—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000223	0.000495	CcSEcCtD
Naltrexone—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000223	0.000495	CcSEcCtD
Naltrexone—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000223	0.000493	CcSEcCtD
Naltrexone—Dizziness—Cyclosporine—rheumatoid arthritis	0.000223	0.000493	CcSEcCtD
Naltrexone—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000223	0.000493	CcSEcCtD
Naltrexone—Oedema—Prednisone—rheumatoid arthritis	0.000223	0.000493	CcSEcCtD
Naltrexone—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000222	0.000492	CcSEcCtD
Naltrexone—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000222	0.000492	CcSEcCtD
Naltrexone—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000222	0.000492	CcSEcCtD
Naltrexone—Infection—Prednisone—rheumatoid arthritis	0.000221	0.00049	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000221	0.000489	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000221	0.000489	CcSEcCtD
Naltrexone—Back pain—Methotrexate—rheumatoid arthritis	0.00022	0.000488	CcSEcCtD
Naltrexone—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.00022	0.000488	CcSEcCtD
Naltrexone—Fatigue—Dexamethasone—rheumatoid arthritis	0.00022	0.000488	CcSEcCtD
Naltrexone—Fatigue—Betamethasone—rheumatoid arthritis	0.00022	0.000488	CcSEcCtD
Naltrexone—Shock—Prednisone—rheumatoid arthritis	0.000219	0.000485	CcSEcCtD
Naltrexone—Pain—Dexamethasone—rheumatoid arthritis	0.000219	0.000484	CcSEcCtD
Naltrexone—Pain—Betamethasone—rheumatoid arthritis	0.000219	0.000484	CcSEcCtD
Naltrexone—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000218	0.000484	CcSEcCtD
Naltrexone—Tachycardia—Prednisone—rheumatoid arthritis	0.000217	0.000481	CcSEcCtD
Naltrexone—Skin disorder—Prednisone—rheumatoid arthritis	0.000216	0.000479	CcSEcCtD
Naltrexone—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000215	0.000477	CcSEcCtD
Naltrexone—Vision blurred—Methotrexate—rheumatoid arthritis	0.000215	0.000476	CcSEcCtD
Naltrexone—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000215	0.000476	CcSEcCtD
Naltrexone—Vomiting—Cyclosporine—rheumatoid arthritis	0.000214	0.000474	CcSEcCtD
Naltrexone—Rash—Cyclosporine—rheumatoid arthritis	0.000212	0.00047	CcSEcCtD
Naltrexone—Anorexia—Prednisone—rheumatoid arthritis	0.000212	0.00047	CcSEcCtD
Naltrexone—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000212	0.00047	CcSEcCtD
Naltrexone—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000212	0.000469	CcSEcCtD
Naltrexone—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.000211	0.000469	CcSEcCtD
Naltrexone—Headache—Cyclosporine—rheumatoid arthritis	0.000211	0.000467	CcSEcCtD
Naltrexone—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000211	0.000467	CcSEcCtD
Naltrexone—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000211	0.000467	CcSEcCtD
Naltrexone—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000209	0.000463	CcSEcCtD
Naltrexone—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000209	0.000463	CcSEcCtD
Naltrexone—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000208	0.00046	CcSEcCtD
Naltrexone—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000207	0.000459	CcSEcCtD
Naltrexone—Malaise—Methotrexate—rheumatoid arthritis	0.000206	0.000455	CcSEcCtD
Naltrexone—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000205	0.000453	CcSEcCtD
Naltrexone—Urticaria—Dexamethasone—rheumatoid arthritis	0.000203	0.00045	CcSEcCtD
Naltrexone—Urticaria—Betamethasone—rheumatoid arthritis	0.000203	0.00045	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000203	0.000449	CcSEcCtD
Naltrexone—Dizziness—Prednisolone—rheumatoid arthritis	0.000203	0.000449	CcSEcCtD
Naltrexone—Asthenia—Triamcinolone—rheumatoid arthritis	0.000202	0.000448	CcSEcCtD
Naltrexone—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000202	0.000448	CcSEcCtD
Naltrexone—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000202	0.000448	CcSEcCtD
Naltrexone—Body temperature increased—Betamethasone—rheumatoid arthritis	0.000202	0.000448	CcSEcCtD
Naltrexone—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.000202	0.000448	CcSEcCtD
Naltrexone—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000202	0.000447	CcSEcCtD
Naltrexone—Insomnia—Prednisone—rheumatoid arthritis	0.000201	0.000446	CcSEcCtD
Naltrexone—Nausea—Cyclosporine—rheumatoid arthritis	0.0002	0.000443	CcSEcCtD
Naltrexone—Paraesthesia—Prednisone—rheumatoid arthritis	0.0002	0.000443	CcSEcCtD
Naltrexone—Pruritus—Triamcinolone—rheumatoid arthritis	0.000199	0.000442	CcSEcCtD
Naltrexone—Cough—Methotrexate—rheumatoid arthritis	0.000199	0.000441	CcSEcCtD
Naltrexone—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000199	0.000441	CcSEcCtD
Naltrexone—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000198	0.000438	CcSEcCtD
Naltrexone—Convulsion—Methotrexate—rheumatoid arthritis	0.000197	0.000438	CcSEcCtD
Naltrexone—Arthralgia—Methotrexate—rheumatoid arthritis	0.000194	0.00043	CcSEcCtD
Naltrexone—Myalgia—Methotrexate—rheumatoid arthritis	0.000194	0.00043	CcSEcCtD
Naltrexone—Chest pain—Methotrexate—rheumatoid arthritis	0.000194	0.00043	CcSEcCtD
Naltrexone—Decreased appetite—Prednisone—rheumatoid arthritis	0.000193	0.000429	CcSEcCtD
Naltrexone—Rash—Prednisolone—rheumatoid arthritis	0.000193	0.000428	CcSEcCtD
Naltrexone—Dermatitis—Prednisolone—rheumatoid arthritis	0.000193	0.000428	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000193	0.000427	CcSEcCtD
Naltrexone—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000192	0.000426	CcSEcCtD
Naltrexone—Fatigue—Prednisone—rheumatoid arthritis	0.000192	0.000425	CcSEcCtD
Naltrexone—Headache—Prednisolone—rheumatoid arthritis	0.000192	0.000425	CcSEcCtD
Naltrexone—Discomfort—Methotrexate—rheumatoid arthritis	0.000192	0.000425	CcSEcCtD
Naltrexone—Constipation—Prednisone—rheumatoid arthritis	0.00019	0.000422	CcSEcCtD
Naltrexone—Vomiting—Hydrocortisone—rheumatoid arthritis	0.00019	0.000421	CcSEcCtD
Naltrexone—Rash—Hydrocortisone—rheumatoid arthritis	0.000189	0.000418	CcSEcCtD
Naltrexone—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000188	0.000418	CcSEcCtD
Naltrexone—Confusional state—Methotrexate—rheumatoid arthritis	0.000188	0.000416	CcSEcCtD
Naltrexone—Headache—Hydrocortisone—rheumatoid arthritis	0.000187	0.000415	CcSEcCtD
Naltrexone—Dizziness—Triamcinolone—rheumatoid arthritis	0.000186	0.000413	CcSEcCtD
Naltrexone—Anaphylactic shock—Methotrexate—rheumatoid arthritis	0.000186	0.000412	CcSEcCtD
Naltrexone—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000186	0.000412	CcSEcCtD
Naltrexone—Infection—Methotrexate—rheumatoid arthritis	0.000185	0.000409	CcSEcCtD
Naltrexone—Feeling abnormal—Prednisone—rheumatoid arthritis	0.000183	0.000406	CcSEcCtD
Naltrexone—Asthenia—Betamethasone—rheumatoid arthritis	0.000183	0.000406	CcSEcCtD
Naltrexone—Asthenia—Dexamethasone—rheumatoid arthritis	0.000183	0.000406	CcSEcCtD
Naltrexone—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000182	0.000404	CcSEcCtD
Naltrexone—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000182	0.000403	CcSEcCtD
Naltrexone—Nausea—Prednisolone—rheumatoid arthritis	0.000182	0.000403	CcSEcCtD
Naltrexone—Pruritus—Dexamethasone—rheumatoid arthritis	0.000181	0.000401	CcSEcCtD
Naltrexone—Pruritus—Betamethasone—rheumatoid arthritis	0.000181	0.000401	CcSEcCtD
Naltrexone—Skin disorder—Methotrexate—rheumatoid arthritis	0.000181	0.0004	CcSEcCtD
Naltrexone—Hyperhidrosis—Methotrexate—rheumatoid arthritis	0.00018	0.000398	CcSEcCtD
Naltrexone—Vomiting—Triamcinolone—rheumatoid arthritis	0.000179	0.000397	CcSEcCtD
Naltrexone—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000179	0.000396	CcSEcCtD
Naltrexone—Nausea—Hydrocortisone—rheumatoid arthritis	0.000178	0.000394	CcSEcCtD
Naltrexone—Rash—Triamcinolone—rheumatoid arthritis	0.000178	0.000394	CcSEcCtD
Naltrexone—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000177	0.000393	CcSEcCtD
Naltrexone—Anorexia—Methotrexate—rheumatoid arthritis	0.000177	0.000393	CcSEcCtD
Naltrexone—Rash—Methylprednisolone—rheumatoid arthritis	0.000177	0.000393	CcSEcCtD
Naltrexone—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000177	0.000392	CcSEcCtD
Naltrexone—Urticaria—Prednisone—rheumatoid arthritis	0.000177	0.000392	CcSEcCtD
Naltrexone—Headache—Triamcinolone—rheumatoid arthritis	0.000176	0.000391	CcSEcCtD
Naltrexone—Headache—Methylprednisolone—rheumatoid arthritis	0.000176	0.00039	CcSEcCtD
Naltrexone—Abdominal pain—Prednisone—rheumatoid arthritis	0.000176	0.00039	CcSEcCtD
Naltrexone—Body temperature increased—Prednisone—rheumatoid arthritis	0.000176	0.00039	CcSEcCtD
Naltrexone—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000175	0.000387	CcSEcCtD
Naltrexone—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000175	0.000387	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.000169	0.000375	CcSEcCtD
Naltrexone—Dizziness—Dexamethasone—rheumatoid arthritis	0.000169	0.000374	CcSEcCtD
Naltrexone—Dizziness—Betamethasone—rheumatoid arthritis	0.000169	0.000374	CcSEcCtD
Naltrexone—Insomnia—Methotrexate—rheumatoid arthritis	0.000168	0.000373	CcSEcCtD
Naltrexone—Nausea—Triamcinolone—rheumatoid arthritis	0.000167	0.000371	CcSEcCtD
Naltrexone—Paraesthesia—Methotrexate—rheumatoid arthritis	0.000167	0.00037	CcSEcCtD
Naltrexone—Nausea—Methylprednisolone—rheumatoid arthritis	0.000167	0.00037	CcSEcCtD
Naltrexone—Dyspnoea—Methotrexate—rheumatoid arthritis	0.000166	0.000367	CcSEcCtD
Naltrexone—Somnolence—Methotrexate—rheumatoid arthritis	0.000165	0.000366	CcSEcCtD
Naltrexone—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000164	0.000363	CcSEcCtD
Naltrexone—Vomiting—Betamethasone—rheumatoid arthritis	0.000163	0.00036	CcSEcCtD
Naltrexone—Vomiting—Dexamethasone—rheumatoid arthritis	0.000163	0.00036	CcSEcCtD
Naltrexone—Decreased appetite—Methotrexate—rheumatoid arthritis	0.000162	0.000358	CcSEcCtD
Naltrexone—Rash—Betamethasone—rheumatoid arthritis	0.000161	0.000357	CcSEcCtD
Naltrexone—Rash—Dexamethasone—rheumatoid arthritis	0.000161	0.000357	CcSEcCtD
Naltrexone—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000161	0.000357	CcSEcCtD
Naltrexone—Dermatitis—Betamethasone—rheumatoid arthritis	0.000161	0.000357	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000161	0.000356	CcSEcCtD
Naltrexone—Fatigue—Methotrexate—rheumatoid arthritis	0.00016	0.000355	CcSEcCtD
Naltrexone—Headache—Betamethasone—rheumatoid arthritis	0.00016	0.000355	CcSEcCtD
Naltrexone—Headache—Dexamethasone—rheumatoid arthritis	0.00016	0.000355	CcSEcCtD
Naltrexone—Asthenia—Prednisone—rheumatoid arthritis	0.00016	0.000354	CcSEcCtD
Naltrexone—Pain—Methotrexate—rheumatoid arthritis	0.000159	0.000352	CcSEcCtD
Naltrexone—Pruritus—Prednisone—rheumatoid arthritis	0.000157	0.000349	CcSEcCtD
Naltrexone—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.000153	0.00034	CcSEcCtD
Naltrexone—Diarrhoea—Prednisone—rheumatoid arthritis	0.000152	0.000337	CcSEcCtD
Naltrexone—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000152	0.000337	CcSEcCtD
Naltrexone—Nausea—Betamethasone—rheumatoid arthritis	0.000152	0.000336	CcSEcCtD
Naltrexone—Nausea—Dexamethasone—rheumatoid arthritis	0.000152	0.000336	CcSEcCtD
Naltrexone—Urticaria—Methotrexate—rheumatoid arthritis	0.000148	0.000327	CcSEcCtD
Naltrexone—Dizziness—Prednisone—rheumatoid arthritis	0.000147	0.000326	CcSEcCtD
Naltrexone—Body temperature increased—Methotrexate—rheumatoid arthritis	0.000147	0.000326	CcSEcCtD
Naltrexone—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000147	0.000326	CcSEcCtD
Naltrexone—Vomiting—Prednisone—rheumatoid arthritis	0.000142	0.000314	CcSEcCtD
Naltrexone—Rash—Prednisone—rheumatoid arthritis	0.00014	0.000311	CcSEcCtD
Naltrexone—Dermatitis—Prednisone—rheumatoid arthritis	0.00014	0.000311	CcSEcCtD
Naltrexone—Headache—Prednisone—rheumatoid arthritis	0.000139	0.000309	CcSEcCtD
Naltrexone—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.000137	0.000304	CcSEcCtD
Naltrexone—Asthenia—Methotrexate—rheumatoid arthritis	0.000133	0.000296	CcSEcCtD
Naltrexone—Nausea—Prednisone—rheumatoid arthritis	0.000132	0.000293	CcSEcCtD
Naltrexone—Pruritus—Methotrexate—rheumatoid arthritis	0.000132	0.000292	CcSEcCtD
Naltrexone—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000127	0.000282	CcSEcCtD
Naltrexone—Dizziness—Methotrexate—rheumatoid arthritis	0.000123	0.000273	CcSEcCtD
Naltrexone—Vomiting—Methotrexate—rheumatoid arthritis	0.000118	0.000262	CcSEcCtD
Naltrexone—Rash—Methotrexate—rheumatoid arthritis	0.000117	0.00026	CcSEcCtD
Naltrexone—Dermatitis—Methotrexate—rheumatoid arthritis	0.000117	0.00026	CcSEcCtD
Naltrexone—Headache—Methotrexate—rheumatoid arthritis	0.000117	0.000258	CcSEcCtD
Naltrexone—Nausea—Methotrexate—rheumatoid arthritis	0.00011	0.000245	CcSEcCtD
Naltrexone—OPRD1—Signaling by GPCR—CSF2—rheumatoid arthritis	8.31e-05	0.000523	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	8.26e-05	0.000519	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—IL2RA—rheumatoid arthritis	8.25e-05	0.000519	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—BDKRB2—rheumatoid arthritis	8.22e-05	0.000517	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CXCL12—rheumatoid arthritis	8.22e-05	0.000517	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NCF2—rheumatoid arthritis	8.19e-05	0.000515	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—C3—rheumatoid arthritis	8.18e-05	0.000514	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CCL5—rheumatoid arthritis	8.15e-05	0.000512	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL2RB—rheumatoid arthritis	8.13e-05	0.000512	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—ADRBK1—rheumatoid arthritis	8.13e-05	0.000511	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ALOX5—rheumatoid arthritis	8.12e-05	0.000511	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CSF2—rheumatoid arthritis	8.02e-05	0.000505	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCL13—rheumatoid arthritis	8.01e-05	0.000504	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CXCL10—rheumatoid arthritis	8e-05	0.000503	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—SH2B3—rheumatoid arthritis	7.99e-05	0.000502	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TRAF6—rheumatoid arthritis	7.99e-05	0.000502	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—GZMB—rheumatoid arthritis	7.94e-05	0.000499	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	7.89e-05	0.000496	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—C5—rheumatoid arthritis	7.86e-05	0.000494	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—CXCL8—rheumatoid arthritis	7.85e-05	0.000494	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—MMP3—rheumatoid arthritis	7.84e-05	0.000493	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NFATC1—rheumatoid arthritis	7.73e-05	0.000486	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCL3—rheumatoid arthritis	7.7e-05	0.000485	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CXCL2—rheumatoid arthritis	7.7e-05	0.000485	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—RASGRP1—rheumatoid arthritis	7.66e-05	0.000482	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CCR5—rheumatoid arthritis	7.6e-05	0.000478	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—SAA1—rheumatoid arthritis	7.54e-05	0.000474	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—PRKCQ—rheumatoid arthritis	7.5e-05	0.000472	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL2RA—rheumatoid arthritis	7.49e-05	0.000471	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—C3—rheumatoid arthritis	7.43e-05	0.000467	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CCL5—rheumatoid arthritis	7.4e-05	0.000465	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCR6—rheumatoid arthritis	7.39e-05	0.000465	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NCF1—rheumatoid arthritis	7.38e-05	0.000464	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CCR5—rheumatoid arthritis	7.34e-05	0.000462	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CSF2—rheumatoid arthritis	7.29e-05	0.000458	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CXCL10—rheumatoid arthritis	7.26e-05	0.000457	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—IL2RA—rheumatoid arthritis	7.23e-05	0.000455	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IRAK1—rheumatoid arthritis	7.21e-05	0.000454	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TLE3—rheumatoid arthritis	7.21e-05	0.000454	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NCF2—rheumatoid arthritis	7.19e-05	0.000452	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—C3—rheumatoid arthritis	7.17e-05	0.000451	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CX3CR1—rheumatoid arthritis	7.14e-05	0.000449	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CD28—rheumatoid arthritis	7.1e-05	0.000446	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SH2B3—rheumatoid arthritis	7e-05	0.00044	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TRAF6—rheumatoid arthritis	7e-05	0.00044	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—GZMB—rheumatoid arthritis	6.96e-05	0.000438	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CCL5—rheumatoid arthritis	6.88e-05	0.000433	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL2RB—rheumatoid arthritis	6.87e-05	0.000432	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CSF2—rheumatoid arthritis	6.78e-05	0.000426	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CXCL2—rheumatoid arthritis	6.76e-05	0.000425	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCL3—rheumatoid arthritis	6.76e-05	0.000425	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PLD4—rheumatoid arthritis	6.72e-05	0.000422	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—UBE2D1—rheumatoid arthritis	6.68e-05	0.00042	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CCR5—rheumatoid arthritis	6.66e-05	0.000419	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—C5—rheumatoid arthritis	6.64e-05	0.000418	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CXCL8—rheumatoid arthritis	6.64e-05	0.000417	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—MMP3—rheumatoid arthritis	6.62e-05	0.000417	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ENO1—rheumatoid arthritis	6.62e-05	0.000416	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SAA1—rheumatoid arthritis	6.61e-05	0.000416	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL2RA—rheumatoid arthritis	6.57e-05	0.000413	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CXCL12—rheumatoid arthritis	6.55e-05	0.000412	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—BDKRB2—rheumatoid arthritis	6.55e-05	0.000412	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—POMC—rheumatoid arthritis	6.54e-05	0.000411	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NFATC1—rheumatoid arthritis	6.53e-05	0.000411	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—C3—rheumatoid arthritis	6.51e-05	0.00041	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL6ST—rheumatoid arthritis	6.49e-05	0.000408	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ACAN—rheumatoid arthritis	6.49e-05	0.000408	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ADRBK1—rheumatoid arthritis	6.48e-05	0.000407	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NCF1—rheumatoid arthritis	6.47e-05	0.000407	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	6.26e-05	0.000394	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CCL5—rheumatoid arthritis	6.25e-05	0.000393	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCR6—rheumatoid arthritis	6.24e-05	0.000393	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CD28—rheumatoid arthritis	6.22e-05	0.000391	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CCR5—rheumatoid arthritis	6.2e-05	0.00039	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CSF2—rheumatoid arthritis	6.16e-05	0.000387	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—IL2RA—rheumatoid arthritis	6.11e-05	0.000384	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—RASGRP1—rheumatoid arthritis	6.11e-05	0.000384	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—SLC25A12—rheumatoid arthritis	6.1e-05	0.000384	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—SYK—rheumatoid arthritis	6.09e-05	0.000383	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NCF2—rheumatoid arthritis	6.07e-05	0.000382	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—C3—rheumatoid arthritis	6.06e-05	0.000381	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.98e-05	0.000376	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—POMC—rheumatoid arthritis	5.94e-05	0.000374	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GC—rheumatoid arthritis	5.93e-05	0.000373	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PTGES—rheumatoid arthritis	5.93e-05	0.000373	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TRAF6—rheumatoid arthritis	5.92e-05	0.000372	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SH2B3—rheumatoid arthritis	5.92e-05	0.000372	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GZMB—rheumatoid arthritis	5.88e-05	0.00037	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—STAT1—rheumatoid arthritis	5.87e-05	0.000369	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—UBE2D1—rheumatoid arthritis	5.86e-05	0.000368	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CCL2—rheumatoid arthritis	5.81e-05	0.000366	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL6R—rheumatoid arthritis	5.79e-05	0.000364	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CXCL10—rheumatoid arthritis	5.79e-05	0.000364	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—BDKRB2—rheumatoid arthritis	5.74e-05	0.000361	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CXCL12—rheumatoid arthritis	5.74e-05	0.000361	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—POMC—rheumatoid arthritis	5.74e-05	0.000361	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCL3—rheumatoid arthritis	5.71e-05	0.000359	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCL2—rheumatoid arthritis	5.71e-05	0.000359	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL6ST—rheumatoid arthritis	5.69e-05	0.000358	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ADRBK1—rheumatoid arthritis	5.68e-05	0.000357	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CCR5—rheumatoid arthritis	5.63e-05	0.000354	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SAA1—rheumatoid arthritis	5.58e-05	0.000351	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL2RA—rheumatoid arthritis	5.55e-05	0.000349	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PLB1—rheumatoid arthritis	5.51e-05	0.000347	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—C3—rheumatoid arthritis	5.5e-05	0.000346	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NCF1—rheumatoid arthritis	5.47e-05	0.000344	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	5.43e-05	0.000342	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—RASGRP1—rheumatoid arthritis	5.36e-05	0.000337	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SYK—rheumatoid arthritis	5.34e-05	0.000336	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	5.34e-05	0.000336	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MMP3—rheumatoid arthritis	5.28e-05	0.000332	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—TYK2—rheumatoid arthritis	5.28e-05	0.000332	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CD28—rheumatoid arthritis	5.26e-05	0.000331	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.24e-05	0.00033	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—POMC—rheumatoid arthritis	5.21e-05	0.000328	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—STAT1—rheumatoid arthritis	5.15e-05	0.000324	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CCL2—rheumatoid arthritis	5.1e-05	0.000321	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PTK2—rheumatoid arthritis	5.08e-05	0.00032	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL6R—rheumatoid arthritis	5.08e-05	0.00032	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CXCL10—rheumatoid arthritis	5.08e-05	0.000319	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	5.06e-05	0.000318	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCL5—rheumatoid arthritis	4.98e-05	0.000313	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—UBE2D1—rheumatoid arthritis	4.95e-05	0.000311	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	4.93e-05	0.00031	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CSF2—rheumatoid arthritis	4.91e-05	0.000309	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCL12—rheumatoid arthritis	4.85e-05	0.000305	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—BDKRB2—rheumatoid arthritis	4.85e-05	0.000305	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—POMC—rheumatoid arthritis	4.85e-05	0.000305	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—IL2—rheumatoid arthritis	4.84e-05	0.000304	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—MED1—rheumatoid arthritis	4.84e-05	0.000304	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL6ST—rheumatoid arthritis	4.81e-05	0.000303	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ADRBK1—rheumatoid arthritis	4.8e-05	0.000302	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CAT—rheumatoid arthritis	4.76e-05	0.0003	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MMP3—rheumatoid arthritis	4.63e-05	0.000291	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—TYK2—rheumatoid arthritis	4.63e-05	0.000291	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—SPP1—rheumatoid arthritis	4.62e-05	0.00029	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.6e-05	0.000289	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—RASGRP1—rheumatoid arthritis	4.53e-05	0.000285	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	4.52e-05	0.000285	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SYK—rheumatoid arthritis	4.51e-05	0.000284	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—B3GNT2—rheumatoid arthritis	4.5e-05	0.000283	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ACP5—rheumatoid arthritis	4.5e-05	0.000283	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCR5—rheumatoid arthritis	4.49e-05	0.000282	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PTK2—rheumatoid arthritis	4.46e-05	0.00028	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	4.44e-05	0.000279	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PRKCQ—rheumatoid arthritis	4.43e-05	0.000279	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL2RA—rheumatoid arthritis	4.42e-05	0.000278	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—POMC—rheumatoid arthritis	4.4e-05	0.000277	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL2—rheumatoid arthritis	4.39e-05	0.000276	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—C3—rheumatoid arthritis	4.39e-05	0.000276	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCL5—rheumatoid arthritis	4.37e-05	0.000275	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—STAT1—rheumatoid arthritis	4.35e-05	0.000274	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CCL2—rheumatoid arthritis	4.31e-05	0.000271	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CSF2—rheumatoid arthritis	4.3e-05	0.000271	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL6R—rheumatoid arthritis	4.29e-05	0.00027	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCL10—rheumatoid arthritis	4.29e-05	0.00027	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—IL2—rheumatoid arthritis	4.24e-05	0.000267	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	4.22e-05	0.000266	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—LEP—rheumatoid arthritis	4.08e-05	0.000257	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—BGN—rheumatoid arthritis	4.05e-05	0.000255	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SPP1—rheumatoid arthritis	4.05e-05	0.000255	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.03e-05	0.000253	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—MTHFR—rheumatoid arthritis	3.98e-05	0.00025	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCR5—rheumatoid arthritis	3.94e-05	0.000248	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MMP3—rheumatoid arthritis	3.91e-05	0.000246	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—TYK2—rheumatoid arthritis	3.91e-05	0.000246	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL2RA—rheumatoid arthritis	3.88e-05	0.000244	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—FN1—rheumatoid arthritis	3.85e-05	0.000242	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL2—rheumatoid arthritis	3.85e-05	0.000242	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—C3—rheumatoid arthritis	3.85e-05	0.000242	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL6ST—rheumatoid arthritis	3.84e-05	0.000241	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PTK2—rheumatoid arthritis	3.77e-05	0.000237	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.75e-05	0.000236	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ALOX5—rheumatoid arthritis	3.73e-05	0.000234	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	3.72e-05	0.000234	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCL5—rheumatoid arthritis	3.69e-05	0.000232	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CD80—rheumatoid arthritis	3.69e-05	0.000232	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CSF2—rheumatoid arthritis	3.64e-05	0.000229	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—IL2—rheumatoid arthritis	3.58e-05	0.000225	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—LEP—rheumatoid arthritis	3.58e-05	0.000225	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—POMC—rheumatoid arthritis	3.51e-05	0.000221	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCL2—rheumatoid arthritis	3.43e-05	0.000216	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL6R—rheumatoid arthritis	3.42e-05	0.000215	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SPP1—rheumatoid arthritis	3.42e-05	0.000215	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.41e-05	0.000214	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—FN1—rheumatoid arthritis	3.38e-05	0.000212	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL6ST—rheumatoid arthritis	3.36e-05	0.000212	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCR5—rheumatoid arthritis	3.33e-05	0.000209	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL2RA—rheumatoid arthritis	3.28e-05	0.000206	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL2—rheumatoid arthritis	3.25e-05	0.000205	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—C3—rheumatoid arthritis	3.25e-05	0.000204	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CD80—rheumatoid arthritis	3.24e-05	0.000204	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—POMC—rheumatoid arthritis	3.18e-05	0.0002	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TYK2—rheumatoid arthritis	3.12e-05	0.000196	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—POMC—rheumatoid arthritis	3.08e-05	0.000194	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NOS3—rheumatoid arthritis	3.06e-05	0.000192	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ENO1—rheumatoid arthritis	3.04e-05	0.000191	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—LEP—rheumatoid arthritis	3.03e-05	0.00019	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCL2—rheumatoid arthritis	3.01e-05	0.000189	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL6R—rheumatoid arthritis	3e-05	0.000189	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ALB—rheumatoid arthritis	2.9e-05	0.000182	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—FN1—rheumatoid arthritis	2.85e-05	0.00018	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL6ST—rheumatoid arthritis	2.84e-05	0.000179	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.84e-05	0.000179	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—NOS3—rheumatoid arthritis	2.77e-05	0.000174	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CD80—rheumatoid arthritis	2.74e-05	0.000172	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TYK2—rheumatoid arthritis	2.73e-05	0.000172	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.71e-05	0.000171	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NOS3—rheumatoid arthritis	2.68e-05	0.000169	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—POMC—rheumatoid arthritis	2.6e-05	0.000164	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL2—rheumatoid arthritis	2.59e-05	0.000163	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL6—rheumatoid arthritis	2.58e-05	0.000162	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCL2—rheumatoid arthritis	2.54e-05	0.00016	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL6R—rheumatoid arthritis	2.54e-05	0.00016	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PTGS2—rheumatoid arthritis	2.54e-05	0.00016	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MMP9—rheumatoid arthritis	2.46e-05	0.000154	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.43e-05	0.000153	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.39e-05	0.00015	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.38e-05	0.00015	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TYK2—rheumatoid arthritis	2.31e-05	0.000145	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL2—rheumatoid arthritis	2.27e-05	0.000143	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NOS3—rheumatoid arthritis	2.27e-05	0.000143	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL6—rheumatoid arthritis	2.26e-05	0.000142	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—VEGFA—rheumatoid arthritis	2.2e-05	0.000139	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CAT—rheumatoid arthritis	2.19e-05	0.000137	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MMP9—rheumatoid arthritis	2.15e-05	0.000135	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.13e-05	0.000134	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.09e-05	0.000132	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TGFB1—rheumatoid arthritis	2.02e-05	0.000127	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.01e-05	0.000127	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.93e-05	0.000122	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL2—rheumatoid arthritis	1.92e-05	0.000121	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL6—rheumatoid arthritis	1.91e-05	0.00012	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	1.82e-05	0.000115	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MMP9—rheumatoid arthritis	1.82e-05	0.000114	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.8e-05	0.000113	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.77e-05	0.000112	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.77e-05	0.000111	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TP53—rheumatoid arthritis	1.67e-05	0.000105	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.63e-05	0.000103	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL6—rheumatoid arthritis	1.52e-05	9.59e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.5e-05	9.43e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TP53—rheumatoid arthritis	1.46e-05	9.19e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—POMC—rheumatoid arthritis	1.46e-05	9.18e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL6—rheumatoid arthritis	1.34e-05	8.41e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ALB—rheumatoid arthritis	1.33e-05	8.37e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—NOS3—rheumatoid arthritis	1.27e-05	8e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TP53—rheumatoid arthritis	1.23e-05	7.76e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	1.16e-05	7.32e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL6—rheumatoid arthritis	1.13e-05	7.11e-05	CbGpPWpGaD
